Calls
1
Tony Ho
CFO, 3SBio
Win Rate
-
return
-
Ticker
Side
Mentions
First Call
Call Price
P&L
Thesis
Theme
Source
Long
Jan 15
$26.90
-
3SBio has strong clinical data, multiple bispecific antibodies in Phase 1/2 trials and US FDA clinical approvals, plus a record Pfizer deal with $1.5 billion upfront and up to $4.8 billion in milestones; management expects busy business development and a promising 2-3 year outlook, with internationalization via Pfizer approvals.
Other
Showing 1 of 1 calls · sorted by mentions
Choose a mentions count to open ticker posts.
Tony Ho has 1 trade ideas tracked on Buzzberg across 1 tickers since January 2026.
Historical call returns are modeled from recorded ideas and stored prices, not actual brokerage portfolio returns. Check the evaluated call set and horizon; past results do not establish future prediction accuracy. Explore our data and methodology
